Table of contents
Volume 95, Issue 4
Published online 15 August 2006 (425-554)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Corrigendum
Minireview
Differential proteomic alterations between localised and metastatic prostate cancer FREE
B S Taylor, S Varambally and A M Chinnaiyan
Br J Cancer 95: 425-430; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603274
Clinical Studies
The views and practice of oncologists towards nutritional support in patients receiving chemotherapy FREE
A Spiro, C Baldwin, A Patterson, J Thomas and H J N Andreyev
Br J Cancer 95: 431-434; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603280
Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials FREE
N Torrance, J Mollison, S Wordsworth, J Gray, Z Miedzybrodzka, N Haites, A Grant, M Campbell, M S Watson, A Clarke and B Wilson
Br J Cancer 95: 435-444; advance online publication, July 11, 2006; doi:10.1038/sj.bjc.6603248
Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients FREE
M Scartozzi, E Galizia, L Verdecchia, R Berardi, F Graziano, V Catalano, P Giordani, D Mari, R R Silva, C Marmorale, C Zingaretti and S Cascinu
Br J Cancer 95: 445-449; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603286
Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma FREE
S Falk, A Anthoney, M Eatock, E Van Cutsem, J Chick, H Glen, J W Valle, D W Drolet, D Albert, D Ferry and J Ajani
Br J Cancer 95: 450-456; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603267
A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer FREE
R Collins, R Trowman, G Norman, K Light, A Birtle, E Fenwick, S Palmer and R Riemsma
Br J Cancer 95: 457-462; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603287
Interleukin-2/interferon-
2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN) FREE
J Atzpodien, H Kirchner, U Rebmann, M Soder, U Gertenbach, M Siebels, J Roigas, R Raschke, S Salm, B Schwindl, S C Müller, S Hauser, C Leiber, E Huland, H Heinzer, S Siemer, B Metzner, H Heynemann, P Fornara and M Reitz , DGCIN – German Cooperative Renal Carcinoma Chemoimmunotherapy Trials Group
Br J Cancer 95: 463-469; advance online publication, August 8, 2006; doi:10.1038/sj.bjc.6603271
Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease) FREE
E C J Phernambucq, B Biesma, E F Smit, M A Paul, A vd Tol, F M Schramel, R J Bolhuis and P E Postmus
Br J Cancer 95: 470-474; advance online publication, August 8, 2006; doi:10.1038/sj.bjc.6603289
Translational Therapeutics
Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells FREE
M K L Fung, H-W Cheung, M-T Ling, A L M Cheung, Y-C Wong and X Wang
Br J Cancer 95: 475-484; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603284
Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells FREE
A K Sinha, S Anand, B J Ortel, Y Chang, Z Mai, T Hasan and E V Maytin
Br J Cancer 95: 485-495; advance online publication, July 25, 2006; doi:10.1038/sj.bjc.6603273
Molecular Diagnostics
Cellular senescence in naevi and immortalisation in melanoma: a role for p16? FREE
V C Gray-Schopfer, S C Cheong, H Chong, J Chow, T Moss, Z A Abdel-Malek, R Marais, D Wynford-Thomas and D C Bennett
Br J Cancer 95: 496-505; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603283
Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation FREE
N Voorzanger-Rousselot, F Juillet, E Mareau, J Zimmermann, T Kalebic and P Garnero
Br J Cancer 95: 506-514; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603285
Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers FREE
C L Clarke, J Sandle, A A Jones, A Sofronis, N R Patani and S R Lakhani
Br J Cancer 95: 515-519; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603298
Heritability of DNA-damage-induced apoptosis and its relationship with age in lymphocytes from female twins FREE
R S Camplejohn, S Hodgson, N Carter, B S Kato and T D Spector
Br J Cancer 95: 520-524; advance online publication, July 4, 2006; doi:10.1038/sj.bjc.6603257
Genetics and Genomics
Interactions between genes involved in the antioxidant defence system and breast cancer risk FREE
M Z Oestergaard, J Tyrer, A Cebrian, M Shah, A M Dunning, B A J Ponder, D F Easton and P D P Pharoah
Br J Cancer 95: 525-531; advance online publication, July 25, 2006; doi:10.1038/sj.bjc.6603272
CEACAM6 gene expression in intrahepatic cholangiocarcinoma FREE
K Ieta, F Tanaka, T Utsunomiya, H Kuwano and M Mori
Br J Cancer 95: 532-540; advance online publication, July 25, 2006; doi:10.1038/sj.bjc.6603276
Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours FREE
Y Satoh, H Nakadate, T Nakagawachi, K Higashimoto, K Joh, Z Masaki, J Uozumi, Y Kaneko, T Mukai and H Soejima
Br J Cancer 95: 541-547; advance online publication, August 8, 2006; doi:10.1038/sj.bjc.6603302
PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study FREE
N Soufir, B Gerard, M Portela, A Brice, M Liboutet, P Saiag, V Descamps, D Kerob, P Wolkenstein, I Gorin, C Lebbe, N Dupin, B Crickx, N Basset-Seguin and B Grandchamp
Br J Cancer 95: 548-553; doi:10.1038/sj.bjc.6603303
Corrigendum
Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia FREE
B U Mueller, T Pabst, P Hauser, G Gilliland, D Neuberg and D G Tenen
Br J Cancer 95: 554; doi:10.1038/sj.bjc.6603264
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
